Vaginal Candidiasis
0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 2 programs with unclassified modality
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Peptonic MedicalVagiVitalAC
BayerMetronidazole/Miconazole
Clinical Trials (2)
Total enrollment: 13,150 patients across 2 trials
Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis
Start: Sep 2021Est. completion: Jun 2022126 patients
N/AUnknown
Observational Program Neo-Penotran® Forte
Start: Oct 2010Est. completion: Apr 201513,024 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.